Jt Stratford LLC Laboratory Corp Of America Holdings Transaction History

Jt Stratford LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$213.32 - $257.83 $376,083 - $454,554	1,763 New	1,763 $404,000
Q3 2022 Nov 14, 2022	BUY	$204.81 - $262.19 $804,084 - $1.03 Million	3,926 Added 91.24%	8,229 $1.69 Million
Q2 2022 Aug 15, 2022	SELL	$213.86 - $277.87 $75,706 - $98,365	-354 Reduced 7.6%	4,303 $1.01 Million
Q1 2022 May 12, 2022	BUY	$259.82 - $298.18 $685,924 - $787,195	2,640 Added 130.89%	4,657 $1.23 Million
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $197,181 - $228,116	726 Added 56.24%	2,017 $634,000
Q3 2021 Nov 15, 2021	BUY	$274.82 - $308.34 $354,792 - $398,066	1,291 New	1,291 $363,000

113

2.32M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

Stay updated on Jt Stratford LLC with notifications on news.